Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Canc

[D.ap]

When a patient on TKIs experiences what we call a non player type tumor , while on what appears to other wise be a successful response overall.
This write up appears to give a good argument to why a patient should be able to move forward with ablative side treatment while being able to resume the TKI after the nonplayer tumor is treated.


http://theoncologist.alphamedpress.org/ ... 8/964.full